TI
VIVO

Trexquant Investment’s Meridian Bioscience Inc VIVO Stock Holding History

Trexquant Investment’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,509
Closed -$212K – 1619
2020
Q3 		$212K Buy
+12,509
New +$243K 0.01% 1061
2020
Q1 		– Sell
-22,374
Closed -$219K – 1515
2019
Q4 		$219K Buy
+22,374
New +$210K 0.01% 879
2019
Q3 		– Sell
-11,884
Closed -$141K – 1186
2019
Q2 		$141K Buy
+11,884
New +$143K 0.01% 719

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's VIVO Position: Q4 2020 in Review

Trexquant Investment sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 12,509 shares — an estimated $212K sold.

Trexquant Investment first reported a position in VIVO in Q2 2019 and held it in 3 quarters. The position peaked at $219K in Q4 2019. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • Trexquant Investment reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • Trexquant Investment sold 12,509 Meridian Bioscience Inc shares in Q4 2020, an estimated $212K.
  • Trexquant Investment first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 3 quarters.
  • Trexquant Investment's Meridian Bioscience Inc position peaked at $219K in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Trexquant Investment's 13F filing for Q4 2020, filed 11 Feb 2021.